These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical results of quadruple drug immunosuppression in liver transplantation. Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217 [No Abstract] [Full Text] [Related]
7. Triple drug maintenance therapy in renal transplantation. Pallardó LM; Sánchez J; Hernandez M; Górriz JL; Sánchez P; Beneyto I; Rochera A Transplant Proc; 1992 Feb; 24(1):58-9. PubMed ID: 1539343 [No Abstract] [Full Text] [Related]
8. Impact of cyclosporine dose on long-term outcome after heart transplantation. Valantine H; Hunt S; Gamberg P; Miller J; Luikart H Transplant Proc; 1994 Oct; 26(5):2710-2. PubMed ID: 7940848 [No Abstract] [Full Text] [Related]
9. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180 [No Abstract] [Full Text] [Related]
10. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation. Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548 [No Abstract] [Full Text] [Related]
11. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M; Latter DA; Loertscher R Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721 [TBL] [Abstract][Full Text] [Related]
12. Unique antithymocyte serum versus OKT3 for induction immunotherapy after heart transplantation. Frist WH; Merrill WH; Eastburn TE; Atkinson JB; Stewart JR; Hammon JW; Bender JW J Heart Transplant; 1990; 9(5):489-94. PubMed ID: 2121921 [TBL] [Abstract][Full Text] [Related]
13. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation? Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020 [TBL] [Abstract][Full Text] [Related]
14. Effect of HLA-DR matching on rejection after cardiac transplantation. Cochrane A; Benson E; Williams T; Bergin P; Esmore D Transplant Proc; 1992 Feb; 24(1):169-70. PubMed ID: 1539227 [No Abstract] [Full Text] [Related]
16. Risk/benefit ratio of perioperative OKT3 in cardiac transplantation. Johnson MR; Mullen GM; O'Sullivan EJ; Liao Y; Heroux AL; Kao W; Pifarre R; Costanzo-Nordin MR Transplant Proc; 1993 Feb; 25(1 Pt 2):1149-51. PubMed ID: 8442068 [TBL] [Abstract][Full Text] [Related]
17. Cytokine-release syndrome: differences between high and low doses of OKT3. Norman DJ; Kimball JA; Barry JM Transplant Proc; 1993 Apr; 25(2 Suppl 1):35-8. PubMed ID: 8465420 [No Abstract] [Full Text] [Related]